The Road to First in Human Trials (Invite-Only)
This session gives biotech leaders a practical roadmap for moving a new asset from development into first-in-human readiness. Attendees will learn how to align CMC, toxicology, regulatory strategy, and early clinical planning around the target product profile so critical decisions are made earlier, risks are surfaced sooner, and resources are deployed more strategically. The discussion […]